<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> promotes <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and has been recognized as an important risk factor for both <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, the precise relationship between <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> recurrence or development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> is uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate the relationship of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> to <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> recurrence or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> in patients with a history of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 32 patients poststroke with <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> but without a history of <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> were asked whether they had experienced <z:hpo ids='HP_0001297'>stroke</z:hpo> recurrence or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> after discharge </plain></SENT>
<SENT sid="4" pm="."><plain>We found that 4 of 32 patients experienced recurrence </plain></SENT>
<SENT sid="5" pm="."><plain>Three of these 4 patients had <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>We classified the subjects into two groups: one group with <z:hpo ids='HP_0001297'>stroke</z:hpo> recurrence and the other group without </plain></SENT>
<SENT sid="7" pm="."><plain>We then compared the insulin profiles between these two groups </plain></SENT>
<SENT sid="8" pm="."><plain>Although there was no significant relationship between recurrence and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> level was higher in patients with recurrence than without </plain></SENT>
<SENT sid="9" pm="."><plain>Insulin-resistant patients with recurrence had significantly lower levels of plasma insulin at 120 minutes in the oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test compared with those without recurrence </plain></SENT>
<SENT sid="10" pm="."><plain>This study suggests that <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in combination with <z:mp ids='MP_0003059'>decreased insulin secretion</z:mp> may be associated with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> recurrence or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> </plain></SENT>
</text></document>